Biomarkers are major tools in drug development and pharmaceutical research. Biomarkers have been recognized in making the drug development process to be more efficient and have become an essential part of Pharmacology and pharmaceutical research. Number of biomarkers are expected that will ultimately transition into the clinical laboratory.
Biomarkers demonstrate drug dose–response relationships between biomarker changes, onset of injury, and severity of injury that correspond to progression of the injury.
Related Conferences: International Conference on Molecular Biology and Stem Cells, November 19-20, 2018 at Paris, France; 12th International Conference on Cancer Stem Cells and Oncology Research, March 15-17, 2019 at Rome, Italy; 9th European Congress on Breast Cancer, Women’s health and Therapeutics, February 25-27, 2019; 2nd World Congress on Stem Cells and Regenerative Medicine, March 14-15, 2019, London, UK
Related Associations: International Pharmaceutical Federation, International Pharmaceutical Students Federation, Pharmaceutical Group of European Union (PGEU), Pharmaceutical Society of Australia.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
